A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines - Nature
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines Nature
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines Nature
Next-generation vaccine adjuvants: Integrating nanotechnology, systems immunology, and computational approaches for precision vaccinology National Institutes of Health (NIH) | (.gov)
COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice Frontiers
Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes Science | AAAS
Vaccine symposium airs multiple ideas for accelerating preventive immunology Stanford Medicine
Rapid boosting increases germinal center responses to sequential vaccines Nature
NC State Avian Immunology Expert Replicates Turkey Vaccine Success in Chickens NC State University
Vaccines: protecting more than you think British Society for Immunology
Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progress Frontiers
Memory B cell development in response to mRNA SARS-CoV-2 and nanoparticle immunization in mice National Institutes of Health (NIH) | (.gov)
Why Vaccines Are Especially Important If You Have Asthma or Allergies American College of Allergy Asthma and Immunology
New Horizons for Immunology and Vaccine Research at Cincinnati Children’s Research Horizons
mRNA-based influenza vaccine expands the B cell response breadth in humans Nature
GenIV vaccines: bridging innovation to equity in neglected tropical diseases Frontiers
Cancer vaccines as enablers of immunotherapy Nature
Immunity to viruses: learning from successful human vaccines National Institutes of Health (NIH) | (.gov)
The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune response Frontiers
A guide to vaccinology: from basic principles to new developments Nature
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans Nature
COVID-19 vaccines: modes of immune activation and future challenges Nature
Eliciting antitumor immunity via therapeutic cancer vaccines Nature
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants Science | AAAS
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults Nature
Immunological considerations for COVID-19 vaccine strategies Nature
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants Frontiers
Viral targets for vaccines against COVID-19 Nature
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice Nature
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination Nature
Mucosal vaccines — fortifying the frontiers Nature
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses Nature
Blood test can predict how long vaccine immunity will last, Stanford Medicine-led study shows Stanford Medicine
Designing Vaccines for the Twenty-First Century Society Frontiers
Glycemic control and vaccine response: the role of mucosal immunity after vaccination in diabetic patients Frontiers
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination Science | AAAS
Immunological factors linked to geographical variation in vaccine responses Nature
Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective Frontiers
Emerging Concepts and Technologies in Vaccine Development Frontiers
Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates Frontiers
Immune signature atlas of vaccines: learning from the good responders Nature
Precision Vaccine Development: Cues From Natural Immunity Frontiers